Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore which Aristocrats ETF is cheapest by examining expense ratios and trading costs across leading funds, helping you minimize fees and maximize returns.
19,765 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Lemonade stock surged about 16% this week thanks to a powerful mix of analyst optimism and progress in its AI-based u...
Across Latin America, a new wave of fintechs is defying expectations. This article dives into three standout players,...
On a day when the markets attempted a comeback, FuboTV stunned traders with a sharp drop. This article breaks down wh...
Two crypto stock heavyweights drop sharply as the Clarity Act targets passive stablecoin yields, threatening Circle’s...
A private AI-focused fund has surged 1,200% on hype around Anthropic and SpaceX, drawing investor demand but also gro...
Bluesky is carving a new path in social media by using an open, federated protocol. This article explains what Bluesk...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
A rough week for stocks left many investors wonder what comes next. This guide breaks down why the Dow tumbled and th...
Ark Invest disclosed a new Alphabet stake, triggering debate over Google’s growth drivers and the broader tech rally....
As AI reshapes markets in 2026, savvy growth investors focus on durable franchises, strong cash flow, and scalable AI...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...